Fudosteine solution preparation for atomization inhalation, and preparation method thereof

A technology of atomized inhalation and fudosteine, which is applied in aerosol delivery, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problem of long-term stability of preparations and gastrointestinal mucosal damage , affect the appearance of the sample and other issues, to achieve the effect of reducing the damage of the whole body organs, especially the liver and kidney, avoiding the first-pass effect, and safe clinical application

Inactive Publication Date: 2019-06-25
SHANGHAI KAIBAO PHARMA +1
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, when it is used together with fillers often used in solid preparations, such as various sugars, cellulose, and sugar alcohols, it will change color, which not only affects the appearance of the sample, but sometimes causes a decrease in the content
[0005] At present, only tablets, granules, and capsules are on the market in China, and most of them are oral preparations, which have poor fluidity and are easy to absorb moisture, which affects the long-term stability of the preparation, and will cause certain damage to the gastrointestinal mucosa when taking them.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fudosteine solution preparation for atomization inhalation, and preparation method thereof
  • Fudosteine solution preparation for atomization inhalation, and preparation method thereof
  • Fudosteine solution preparation for atomization inhalation, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: Fodosteine ​​nebulized inhalation solution preparation 1000mL

[0032] prescription:

[0033]

Embodiment 2

[0034] Embodiment 2: Fodosteine ​​nebulized inhalation solution preparation 1000mL

[0035] prescription:

[0036]

Embodiment 3

[0037] Embodiment 3: Fodosteine ​​nebulized inhalation solution preparation 1000mL

[0038] prescription:

[0039]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a fudosteine solution preparation for atomization inhalation, and a preparation method thereof. A single dose of the fudosteine solution preparation for atomization inhalation comprises the following components: 20-120 mg of fudosteine or a salt and / or a hydrate thereof (based on free fudosteine), 0.5-2 mg of a metal complexing agent, an appropriate amount of a pH regulatorand water for injection. The prepared fudosteine solution preparation for atomization inhalation has the characteristics of high efficiency, low toxicity, good stability and high safety, and is used for treatment of sputum stickiness, expectoration difficulty and phlegm obstruction of trachea and other diseases caused by chronic bronchitis, bronchial asthma and other diseases.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a fudosteine ​​atomized solution preparation for inhalation and a preparation method thereof. Background technique [0002] Due to factors such as dense population, large number of smokers and environmental pollution, the morbidity and mortality of respiratory diseases have remained high in recent years. The cause of death (excluding tumors) rose from 10th in 1970 to 4th (chronic obstructive pulmonary disease) and 8th (pneumonia, influenza and upper respiratory tract infection) in 1991, while respiratory diseases in my country The incidence rate of the disease all accounts for the first of many diseases in any age group. This problem has attracted people's attention day by day, so the development of drugs for treating respiratory diseases (respiratory drugs for short) has also become an important research and development field of drug research. [0003] Cough and expect...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K31/198A61K47/04A61K47/18A61P11/10A61P11/14A61P11/00
CPCA61K9/0073A61K9/08A61K31/198A61K47/12A61K47/183A61P11/00A61P11/10A61P11/14A61K9/0078
Inventor 张保献胡杰
Owner SHANGHAI KAIBAO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products